Lumos Diagnostics Holdings
Lumos Diagnostics Holdings specializes in the development, manufacture, and distribution of point-of-care diagnostic tests and associated readers. The company is positioned as a leader in rapid diagnostics, offering unique solutions like FebriDx, which aids in differentiating bacterial from viral infections at the point of care.
Short position
Lumos Diagnostics Holdings (ASX:LDX) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 5,059 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.87% in June 2022. LDX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Lumos Diagnostics Holdings (LDX) short interest history
LDX Short Interest History
- 30-day change
- -0.00pp
- 90-day change
- -0.00pp
- 1-year change
- -0.01pp
- All-time high
- 0.87% (June 2022)
- All-time low
- 0.00% (October 2025)
Is LDX heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #689 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has LDX's short interest changed recently?
Over the past 30 days Lumos Diagnostics Holdings's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest LDX's short interest has been?
Since 2021, Lumos Diagnostics Holdings's short interest peaked at 0.87% in June 2022 and bottomed at 0.00% in October 2025.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2021. See our methodology.